July 28, 2016 7:38 PM ET

Biotechnology

Company Overview of Arbutus Biopharma Corporation

Executive Profile

Keith S. Manchester M.D.

Independent Non-Executive Director and Chairman of Corporate Governance & Nominating Committee, Arbutus Biopharma Corporation
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
47$83,724

Background

Dr. Keith S. Manchester, M.D. served as a Vice President of Business Development of Applied Molecular Evolution, Inc., from January 2002 to 2004. From 2000 to 2002, Dr. Manchester served as Director of Business Development in Applied Molecular Evolution Inc. From 1999 to 2000, he was an Associate at Vestar Capital Partners. From 1997 to 1999, he was an investment banker in the healthcare group at Goldman, Sachs & Co. He completed his surgical internship at Parkland Medical ...

Corporate Headquarters

100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8

Canada

Phone: 604-419-3200
Fax: 604-419-3201

Board Members Memberships

Director
2015-Present
Independent Non-Executive Director and Chairman of Corporate Governance & Nominating Committee

Education

BA
Harvard College
MD
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$34,246
Total Calculated Compensation$83,724
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph W. Ramelli Chairman, Interim Chief Executive Officer, Interim President, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Marina Biotech, Inc.
--
Gregory West CAInterim Chief Executive Officer, Chief Financial Officer and Company Secretary
Benitec Biopharma Limited
$230.0K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
$446.5K
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$490.0K
Robert W. Overell Ph.D.Co-Founder, Chief Executive Officer, President and Director
PhaseRx, Inc.
$324.2K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Arbutus Biopharma Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.